Zhang Yujing, Wang Lin, Peng Lihua
Microbiota Laboratory, Clinical Division of Microbiota, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Medical School of Chinese PLA, Beijing 100853, China.
Microorganisms. 2025 Mar 31;13(4):794. doi: 10.3390/microorganisms13040794.
Ulcerative colitis (UC) is a chronic inflammatory bowel disease closely associated with dysbiosis of the gut microbiome, encompassing not only bacterial communities but also fungal populations. Despite the growing recognition of the gut microbiome's role in UC pathogenesis, the contribution of intestinal fungi has only recently garnered significant attention. In this review, we comprehensively examine the characteristics of intestinal fungi in both healthy individuals and UC patients, elucidating their role in disease pathogenesis and their interactions with bacterial communities. Additionally, we explore the impact of intestinal fungi on disease severity and therapeutic responses in UC. Furthermore, we evaluate the therapeutic potential of antifungal agents, probiotics, and fecal microbiota transplantation (FMT) in UC management, emphasizing the critical role of fungi in these treatment modalities. Future research should prioritize elucidating the multifunctional roles of fungi in UC pathogenesis and their implications for treatment strategies. Moreover, the identification of fungal biomarkers associated with FMT efficacy could pave the way for precision medicine approaches in FMT, offering novel insights into personalized therapeutic interventions for UC.
溃疡性结肠炎(UC)是一种慢性炎症性肠病,与肠道微生物群失调密切相关,不仅包括细菌群落,还包括真菌种群。尽管肠道微生物群在UC发病机制中的作用越来越受到认可,但肠道真菌的贡献直到最近才受到广泛关注。在这篇综述中,我们全面研究了健康个体和UC患者肠道真菌的特征,阐明了它们在疾病发病机制中的作用以及它们与细菌群落的相互作用。此外,我们探讨了肠道真菌对UC疾病严重程度和治疗反应的影响。此外,我们评估了抗真菌药物、益生菌和粪便微生物群移植(FMT)在UC管理中的治疗潜力,强调了真菌在这些治疗方式中的关键作用。未来的研究应优先阐明真菌在UC发病机制中的多功能作用及其对治疗策略的影响。此外,识别与FMT疗效相关的真菌生物标志物可为FMT的精准医学方法铺平道路,为UC的个性化治疗干预提供新的见解。